BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 8943177)

  • 1. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
    Vecchio E; Fiume G; Mignogna C; Iaccino E; Mimmi S; Maisano D; Trapasso F; Quinto I
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor outcome in hypoxic endometrial carcinoma is related to vascular density.
    Reijnen C; van Weelden WJ; Arts MSJP; Peters JP; Rijken PF; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Krakstad C; Trovik J; Haldorsen IS; Huvila J; Koskas M; Weinberger V; Minar L; Jandakova E; Snijders MPLM; van den Berg-van Erp S; Küsters-Vandevelde HVN; Matias-Guiu X; Amant F; ; Massuger LFAG; Bussink J; Pijnenborg JMA
    Br J Cancer; 2019 May; 120(11):1037-1044. PubMed ID: 31011231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors.
    Goldshaid L; Rubinstein E; Brandis A; Segal D; Leshem N; Brenner O; Kalchenko V; Eren D; Yecheskel T; Salitra Y; Salomon Y; Scherz A
    Breast Cancer Res; 2010; 12(3):R29. PubMed ID: 20497549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast.
    Leek RD; Landers RJ; Harris AL; Lewis CE
    Br J Cancer; 1999 Feb; 79(5-6):991-5. PubMed ID: 10070902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].
    Saji S; Toi M; Tominaga T
    Nihon Geka Gakkai Zasshi; 1996 May; 97(5):368-74. PubMed ID: 8709939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer.
    Kato T; Kimura T; Ishii N; Fujii A; Yamamoto K; Kameoka S; Nishikawa T; Kasajima T
    Breast Cancer Res Treat; 1999 Jan; 53(1):19-31. PubMed ID: 10206069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer.
    Kato T; Kameoka S; Kimura T; Nishikawa T; Kasajima T
    Breast Cancer Res Treat; 2001 Feb; 65(3):203-15. PubMed ID: 11336242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer.
    Kato T; Kameoka S; Kimura T; Soga N; Abe Y; Nishikawa T; Kobayashi M
    Breast Cancer Res Treat; 2001 Nov; 70(1):65-74. PubMed ID: 11767005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer.
    Kato T; Kameoka S; Kimura T; Nishikawa T; Kobayashi M
    Br J Cancer; 2003 Jun; 88(12):1900-8. PubMed ID: 12799634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood vessel invasion as a predictor of long-term survival for Japanese patients with breast cancer.
    Kato T; Kameoka S; Kimura T; Nishikawa T; Kobayashi M
    Breast Cancer Res Treat; 2002 May; 73(1):1-12. PubMed ID: 12083626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic study of angiogenesis in Japanese patients with breast cancer.
    Kato T; Kimura T; Miyakawa R; Tanaka S; Fujii A; Yamamoto K; Kameoka S; Hamano K; Kawakami M; Aiba M
    World J Surg; 1997 Jan; 21(1):49-56. PubMed ID: 8943177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis.
    Heimann R; Ferguson D; Gray S; Hellman S
    Breast Cancer Res Treat; 1998; 52(1-3):147-58. PubMed ID: 10066079
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.